17β-hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.

被引：0
|
作者：
Collin, Lindsay Jane [1 ]
Kjaersgaard, Anders [2 ]
Ahern, Thomas P. [3 ]
Goodman, Michael [4 ]
McCullough, Lauren E. [4 ]
Waller, Lance A. [4 ]
Christensen, Kristina B. [5 ]
Damkier, Per [6 ]
Hamilton-Dutoit, Stephen J. [5 ]
Lauridsen, Kristina [5 ]
Chistiansen, Peer M. [5 ]
Ejlertsen, Bent [7 ]
Sorensen, Henrik Toft [2 ]
Cronin-Fenton, Deirdre [2 ]
Lash, Timothy L. [4 ]
机构：
[1] Huntsman Canc Inst, Salt Lake City, UT USA
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Vermont, Burlington, VT USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Aarhus Univ Hosp, Aarhus, Denmark
[6] Odense Univ Hosp, Odense, Denmark
[7] Danish Breast Canc Grp, Copenhagen, Denmark
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
757
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Compliance With Tamoxifen in Women With Breast Cancer and a BRCA1 or BRCA2 Mutation
    Narod, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : E698 - E699
  • [32] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [33] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [34] Effects of adjuvant tamoxifen over three decades on breast cancerefree and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial
    Ekholm, M.
    Bendahl, P. O.
    Ferno, M.
    Nordenskjold, B.
    Stal, O.
    Ryden, L.
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : 53 - 61
  • [35] Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
    Sotgia, Federica
    Fiorillo, Marco
    Lisanti, Michael P.
    ONCOTARGET, 2017, 8 (40) : 68730 - 68745
  • [36] The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer
    Hilborn, Erik
    Stal, Olle
    Alexeyenko, Andrey
    Jansson, Agneta
    ONCOTARGET, 2017, 8 (37) : 62183 - 62194
  • [37] Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
    Kennecke, Hagen
    McArthur, Heather
    Olivotto, Ivo A.
    Speers, Caroline
    Bajdik, Chris
    Chia, Stephen K.
    Ellard, Susan
    Norris, Brian
    Hayes, Malcolm
    Barnett, Jeff
    Gelmon, Karen A.
    CANCER, 2008, 112 (07) : 1437 - 1444
  • [38] Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2− Advanced Breast Cancer
    Anand A. Dalal
    Geneviève Gauthier
    Patrick Gagnon-Sanschagrin
    Rebecca Burne
    Annie Guérin
    Polly Niravath
    Tania Small
    Advances in Therapy, 2018, 35 : 1356 - 1367
  • [39] Economic Burden of HR+/HER2-Metastatic Breast Cancer Among Adult Premenopausal Women
    Gauthier, Genevieve
    Gagnon-Sanschagrin, Patrick
    Guerin, Annie
    Burne, Rebecca
    Small, Tania
    Niravath, Polly
    Dalal, Anand A.
    ADVANCES IN THERAPY, 2018, 35 (04) : 503 - 514
  • [40] Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2-Advanced Breast Cancer
    Dalal, Anand A.
    Gauthier, Genevieve
    Gagnon-Sanschagrin, Patrick
    Burne, Rebecca
    Guerin, Annie
    Niravath, Polly
    Small, Tania
    ADVANCES IN THERAPY, 2018, 35 (09) : 1356 - 1367
12345